Quotient Sciences is a contract research, development, and manufacturing organization (CRDMO) that supports the pharmaceutical industry. Founded in 1990, the company provides integrated services across the drug development pathway, from formulation and clinical pharmacology trials through to commercial manufacturing. Its team comprises more than 1,000 experts operating from sites in the United States and the United Kingdom.
The company’s proprietary Translational Pharmaceutics® platform integrates clinical activities with real-time cGMP drug product manufacturing. This approach aims to eliminate traditional development silos and accelerate timelines for clients bringing new therapies to market. The technical scope includes formulation development, Phase I/IIa clinical studies, and scalable manufacturing.
Quotient Sciences has been recognized with multiple industry awards, including CRO Leadership Awards and CDMO Leadership Awards. Its operational culture emphasizes scientific integrity, agility, and collaboration across its global network.
